PixarBio (PixarBio) Scaled Net Operating Assets : 0.97 (As of Sep. 2016)

View and export this data going back to 2016. Start your Free Trial

What is PixarBio Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

PixarBio's operating assets for the quarter that ended in Sep. 2016 was $0.36 Mil. PixarBio's operating liabilities for the quarter that ended in Sep. 2016 was $0.01 Mil. PixarBio's Total Assets for the quarter that ended in Jun. 2016 was $0.37 Mil. Therefore, PixarBio's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2016 was 0.97.

PixarBio Scaled Net Operating Assets Historical Data

The historical data trend for PixarBio's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PixarBio Scaled Net Operating Assets Chart

PixarBio Annual Data

Trend

Dec14

Dec15

Scaled Net Operating Assets

0.92

0.73

PixarBio Quarterly Data
	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16
Scaled Net Operating Assets	Get a 7-Day Free Trial					0.73	0.74	0.63	0.50	0.97

Competitive Comparison of PixarBio's Scaled Net Operating Assets

For the Biotechnology subindustry, PixarBio's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PixarBio's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PixarBio's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where PixarBio's Scaled Net Operating Assets falls into.

PixarBio Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

PixarBio's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2015 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2015 )
=	(Operating Assets (A: Dec. 2015 )	-	Operating Liabilities (A: Dec. 2015 ))	/	Total Assets (A: Dec. 2014 )
=	(0.364	-	0.091)	/	0.376
=	0.73

where

	Operating Assets		(A: Dec. 2015 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.369	-	0.005
=	0.364

	Operating Liabilities		(A: Dec. 2015 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.091	-	0	-	0
=	0.091

PixarBio's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2016 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2016 )
=	(Operating Assets (Q: Sep. 2016 )	-	Operating Liabilities (Q: Sep. 2016 ))	/	Total Assets (Q: Jun. 2016 )
=	(0.358	-	0.005)	/	0.365
=	0.97

where

	Operating Assets		(Q: Sep. 2016 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	0.362	-	0.004
=	0.358

	Operating Liabilities		(Q: Sep. 2016 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	0.005	-	0	-	0
=	0.005

PixarBio Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of PixarBio's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

PixarBio (PixarBio) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PixarBio Corp (GREY:PXRB) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

200 Boston Avenue, Suite 1875, Medford, MA, USA, 02155

Website

https://www.pixarbio.com

PixarBio Corp is a specialty pharmaceutical company focused on preclinical and clinical commercial development of therapeutic drug delivery systems for post-operative pain. The company's lead clinical candidate, NeuroRelease is a non-opioid / non-opiate preclinical stage product intended for the treatment of surgical pain, with planned future indications for chronic pain. NeuroRelease blocks nociceptive and neuropathic pain signals arising from temperature and pressure stimuli without affecting motor function, which is intended to allow for effective treatment without delaying post-surgical physical therapy.